摘要
目的:探讨微生态制剂在儿科临床的应用情况。方法:随机抽取300例门诊患儿的处方,分析其中微生态制剂的应用情况。结果:有24例使用微生态制剂,占处方总数的8%,其中酪酸梭菌肠球菌三联活菌片(适怡)使用率最高,占45.83%(11例)。主要用于治疗呼吸道疾病(7例)、消化系统疾病(10例)、呼吸道疾病合并消化系统疾病(5例)和保健(2例)。微生态制剂与抗生素联用率为41.66%(10例);与消化系统用药联用率为16.67%(4例);无2种或2种以上微生态制剂合用。微生态制剂应用中95.83%(23例)为合理用药;4.17%(1例)为不合理用药(无明显用药指征)。结论:我院儿科微生态制剂的临床应用基本合理。
To study the application situation of the microecological modulators in the department of pediatrics in our hospital.Methods : The clinical data of 300 patients,which treated with microecological modulators were analyzed retrospectively.Results: 24 cases treated with microecological modulators,took up 8% of all the cases.Combination of live Streptococcus faecalis T-110,Clostridium butyricum TO-A and Bacillus mesentericus TO-A tablet was used most frequently(45.83%).Microecological modulators were mainly used to treat respiratory diseases(7 cases),digestive diseases(10 cases),respiratory diseases merge digestive diseases(5 cases)and health(2 cases).The combined application with antibiotics was 41.66%(10 cases).The combined application with medicament of stomach intestine was 16.67%(4 cases).No combined application of microecological modulators was found.95.83%(23 cases)applications of microecological modulators were reasonable while 4.17%(1 case) application of microecological modulators was unreasonable.Conclusions:Most of the applications of microecological modulators in the department of pediatrics in our hospital were reasonable.
出处
《亚太传统医药》
2011年第10期181-182,共2页
Asia-Pacific Traditional Medicine
关键词
微生态制剂
儿科
应用
Microecological Modulator
Pediatrics
Rational Use of Drugs